Emeritus ProfessorCharles Bangham, ScD FMedSci FRS
Emeritus Professor in Immunology
Department of Infectious Disease - Faculty of Medicine
Orcid identifier0000-0003-2624-3599 (opens in a new tab)
- Emeritus Professor in ImmunologyDepartment of Infectious Disease - Faculty of Medicine
- Imperial College London, Institute of Infection, Exhibition Road, London, SW7 2AZ, United Kingdom
BIO
BA Cambridge 1976; BM, BCh Oxford 1980; MRCP (UK) 1983; PhD 1987; FRCPath 1999; FMedSc 2003; ScD Cambridge 2006; FRS 2019.
During my medical training I carried out studies on lung function, genetic polymorphisms, endocrine function and demography in high altitude populations in Nepal. In my PhD I established a model of respiratory syncytial (RS) virus infection in the mouse, and studied the T lymphocyte response to RS virus first in the mouse and then in the human.
Since 1987 I have studied the virology and immunology of persistent virus infections, in particular infection with the human T-cell leukaemia virus (HTLV-I). Our aim is to produce a comprehensive, coherent, qualitative and quantitative understanding of the persistence of HTLV-I and the immune response to HTLV-I, and an explanation of why certain individuals infected with HTLV-I develop fatal or disabling diseases while the majority remain asymptomatic. We use a broad range of techniques in molecular and cellular immunology, viral and host genetics, cell biology, DNA expression microarrays, proteomics and mathematics.
In 2020 I founded the Institute of Infection in Imperial College, whose chief purpose is to drive multidisciplinary research on infection.
During my medical training I carried out studies on lung function, genetic polymorphisms, endocrine function and demography in high altitude populations in Nepal. In my PhD I established a model of respiratory syncytial (RS) virus infection in the mouse, and studied the T lymphocyte response to RS virus first in the mouse and then in the human.
Since 1987 I have studied the virology and immunology of persistent virus infections, in particular infection with the human T-cell leukaemia virus (HTLV-I). Our aim is to produce a comprehensive, coherent, qualitative and quantitative understanding of the persistence of HTLV-I and the immune response to HTLV-I, and an explanation of why certain individuals infected with HTLV-I develop fatal or disabling diseases while the majority remain asymptomatic. We use a broad range of techniques in molecular and cellular immunology, viral and host genetics, cell biology, DNA expression microarrays, proteomics and mathematics.
In 2020 I founded the Institute of Infection in Imperial College, whose chief purpose is to drive multidisciplinary research on infection.
ACADEMIC POSITIONS
- Professor of ImmunologyImperial College London, Department of Medicine, London, United Kingdom1 Nov 1995 - 31 Jan 2023
- Co-DirectorImperial College London, Institute of Infection, London, United Kingdom1 Oct 2020 - 30 Sep 2026
DEGREES
- BAUniversity of Cambridge, Cambridge, United Kingdom1976 - present
- BM BChUniversity of Oxford, Oxford, United Kingdom1980 - present
- MRCPRoyal College of Physicians, London, UK1983 - present
- PhDCNAA, London, UK1987 - present
- FRCPathRoyal College of Pathologists, London, United Kingdom1999 - present
- ScDUniversity of Cambridge, Cambridge, United Kingdom2006 - present
LANGUAGES
- FrenchCan read, write, speak and understand
FACULTY
- Faculty of Medicine
POSITION NAME
- Emeritus Professor in Immunology